Literature DB >> 6635433

Rifampin: spectrum of antibacterial activity.

C Thornsberry, B C Hill, J M Swenson, L K McDougal.   

Abstract

Rifampin was studied for determination of its spectrum of activity against many bacteria of clinical importance. Most of the minimum inhibitory concentrations (MICs) were determined by agar dilution but some were determined by broth microdilution. Staphylococci were the most susceptible, with mode MICs of 0.015 microgram/ml, but most streptococcal strains, except Streptococcus faecalis, had mode MICs less than or equal to 1 microgram/ml. Haemophilus influenzae, Neisseria gonorrhoeae, Neisseria meningitidis, and Listeria monocytogenes were susceptible and had mode MICs of 1, 0.25, 0.03, and less than or equal to 0.12 microgram/ml, respectively. Legionella species had geometric mean MICs ranging from 0.027 to 0.25 microgram/ml. The rapidly growing mycobacteria, Mycobacterium chelonei and Mycobacterium fortuitum, were resistant, with mode of greater than 64 micrograms/ml. Enterobacteriaceae, Acinetobacter species, and Pseudomonas species had mode MICs ranging from 4 to 64 micrograms/ml. Thus, the authors conclude that, on the basis of these in vitro data and an MIC breakpoint of less than or equal to 2 micrograms/ml, gram-positive cocci (except for some enterococci), H. influenzae, N. gonorrhoeae, N. meningitidis, Legionella, and L. monocytogenes may be clinically susceptible to rifampin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6635433     DOI: 10.1093/clinids/5.supplement_3.s412

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  12 in total

Review 1.  Topical antimicrobials for burn infections - an update.

Authors:  Mert Sevgi; Ani Toklu; Daniela Vecchio; Michael R Hamblin
Journal:  Recent Pat Antiinfect Drug Discov       Date:  2013-12

2.  Effects of intraocular rifampicin on retinal ganglion cell structure: a stereological and histopathological study.

Authors:  Ozgür Cakici; Selina Aksak; Deniz Unal; Sare Sipal; Sadullah Keles; Talha Dumlu; Murat Karamese
Journal:  Int J Ophthalmol       Date:  2013-10-18       Impact factor: 1.779

3.  Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.

Authors:  M C Nahata; P Fan-Havard; W J Barson; H M Bartkowski; E J Kosnik
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 4.  Rifamycins, Alone and in Combination.

Authors:  David M Rothstein
Journal:  Cold Spring Harb Perspect Med       Date:  2016-07-01       Impact factor: 6.915

5.  [Multi-step increase in resistance of Neisseria gonorrhoeae isolates after repeated in-vitro subinhibitory concentrations of second-generation quinolones].

Authors:  H C Korting; A Lukacs
Journal:  Infection       Date:  1989       Impact factor: 3.553

Review 6.  Antimicrobial susceptibility of coagulase-negative staphylococci.

Authors:  G L Archer; M W Climo
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

7.  Rifampin resistance of Legionella pneumophila is not increased during therapy for experimental Legionnaires disease: study of rifampin resistance using a guinea pig model of Legionnaires disease.

Authors:  P H Edelstein
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

8.  Rifampin concentrations in various compartments of the human brain: a novel method for determining drug levels in the cerebral extracellular space.

Authors:  T Mindermann; W Zimmerli; O Gratzl
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

9.  What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis.

Authors:  Rein M G J Houben; Marek Lalli; Katharina Kranzer; Nick A Menzies; Samuel G Schumacher; David W Dowdy
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

10.  Enrofloxacin and macrolides alone or in combination with rifampicin as antimicrobial treatment in a bovine model of acute Chlamydia psittaci infection.

Authors:  Annette Prohl; Markus Lohr; Carola Ostermann; Elisabeth Liebler-Tenorio; Angela Berndt; Wieland Schroedl; Michael Rothe; Evelyn Schubert; Konrad Sachse; Petra Reinhold
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.